Portfolio company
Vigil Neuroscience
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
Vigil Neuroscience develops microglia-targeted medicines to treat neurodegenerative diseases for patients with rare and common brain disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Savanna Biotherapeutics
This company develops induced pluripotent stem cell-derived microglia cell therapies to treat patients with neurodegenerative diseases and other central nervous system disorders.
Neurogene Inc
This company develops genetic medicines and gene therapies to treat patients and families affected by rare neurological diseases including Rett syndrome and Batten disease.
Vanqua Bio
This biopharmaceutical firm develops small-molecule therapies for patients with neurodegenerative conditions including Parkinson's disease, Alzheimer's and Gaucher disease.
MindImmune Therapeutics
This company develops monoclonal antibody therapeutics to treat neurodegenerative diseases and neuroinflammation for patients with central nervous system disorders.
Neumora Therapeutics
This biopharmaceutical company develops medicines for patients with neuropsychiatric disorders and neurodegenerative diseases.
Neurosciences
This company develops precision sodium channel therapeutics to treat patients with neurological conditions such as genetic epilepsy and chronic neuropathic pain.
Engrail
This clinical-stage pharmaceutical company develops targeted small-molecule medicines for patients with neuropsychiatric and neurodevelopmental disorders.
Cerevance
This pharmaceutical company develops therapies for neurodegenerative diseases and central nervous system disorders for patients and healthcare providers.
